ALPHA-SYNUCLEIN KINASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110207796A1
SERIAL NO

12865857

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELAN PHARMA INTERNATIONAL LIMITEDTREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, John P San Francisco, US 62 1651
Banducci, Kelly Pleasanton, US 4 10
Basi, Guriqbal S Palo Alto, US 13 62
Chereau, David San Mateo, US 4 10
Chilcote, Tamie J San Fancisco, US 21 379
Frigon,, JR Normand L South San Fancisco, US 3 4
Goldstein, Jason Decatur, US 15 189
Griswold-Prenner, Irene San Francisco, US 31 321

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation